SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-16-013775
Filing Date
2016-06-22
Accepted
2016-06-22 14:33:53
Documents
1
Period of Report
2016-06-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7191330.html 4  
1 OWNERSHIP DOCUMENT p7191330.xml 4 8033
  Complete submission text file 0000919574-16-013775.txt   10512
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Issuer) CIK: 0001327467 (see all company filings)

IRS No.: 202680869 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VALENCE LIFE SCIENCES LLC 500 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address VALENCE LIFE SCIENCES LLC 500 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-891-1100
Valence Life Sciences GP II LLC (Reporting) CIK: 0001576115 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 161726469

Mailing Address VALENCE LIFE SCIENCES LLC 500 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address
Roberts Eric W (Reporting) CIK: 0001576244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 161726467

Mailing Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022 650-843-5000
Valence CDK SPV, L.P. (Reporting) CIK: 0001600038 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 161726468